12 үр дүн
The invention concerns a method for the early diagnosis of cancer in humans.
It is known that cancer cells have macromolecular structures that are more or less specific and in some cases common to the various types of neoplasms. This has been concretely demonstrated by cross immune reactions. In
The present invention is related to apparatus for treating tumors, and more particularly to apparatus for providing a neutron beam particularly advantageous for neutron-capture tumor therapy.
BACKGROUND OF THE INVENTION
An ever increasing number of people are being afflicted with cancer.
The present invention is related to methods for treating tumors, and more particularly to methods for providing a neutron beam particularly advantageous for neutron-capture tumor therapy.
BACKGROUND OF THE INVENTION
An ever increasing number of people are being afflicted with cancer. Conventional
CROSS REFERENCE
The non-provisional application claims priority from Taiwan Patent Application NO. 106127978, filed on Aug. 17, 2017, the content thereof is incorporated by reference herein.
FIELD OF THE INVENTION
The present invention is directed to a pharmaceutical composition, and particularly to
FIELD OF THE INVENTION
This invention relates to the field of immunology, in particular to vaccine compositions able to produce an autoimmune reaction against autologous (self) Epidermal Growth Factor (EGF).
An important object of this invention is to obtain a vaccine composition for the active
BACKGROUND OF THE INVENTION
The present invention is directed to a series of novel phthalocyanines suitable for use as photosensitizers for photodynamic therapy. More particularly, the present invention is directed to a series of new aluminum (Al) and silicon (Si) phthalocyanines having substituted
BACKGROUND OF THE INVENTION
The present invention is directed to a series of novel phthalocyanines suitable for use as photosensitizers for photodynamic therapy. More particularly, the present invention is directed to a series of new aluminum (Al) and silicon (Si) phthalocyanines having substituted
The invention relates to chelate complexes comprising phthalocyanine compounds as complex formers and certain organic derivatives of elements of main groups III and IV of the Periodic Table of Elements having an atomic number of from 31 to 50 inclusive and of aluminium or ruthenium as central atom,
SUMMARY OF THE INVENTION
The present invention relates to pharmaceuticals based on papillomaviruses.
Papillomaviruses induce a variety of lesions both in humans and in animals. Some papillomas, albeit benign, are themselves a clinical problem, such as laryngeal papillomas of children or penile
BACKGROUND OF THE INVENTION
Nearly all life forms require iron as a micronutrient. However, the low solubility of Fe(III) hydroxide (K.sub.sp=1.times.10.sup.-39) (Raymond et al., "Coordination Chemistry and Microbial Iron Transport." Acc. Chem. Res. 1979, 12, 183-190), the predominant form of the
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority of U.S. provisional patent application No. 61/348,764 filed on May 27, 2010 the disclosure of which is incorporated by reference.
TECHNICAL FIELD
The present invention relates to a method for the preparation of a
TECHNICAL FIELD
The present invention relates to a method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the composition made by the process. The present invention also relates to the use of the high-temperature stable oxygen